Safety First: How R3 Stem Cell Prevents Disease Transmission in Regenerative Medicine
Written by Dr. David Greene, MD, PhD, MBA on April 23, 2026
When considering regenerative medicine, the most critical question a patient can ask is: “How do I know this tissue is safe?” At R3 Stem Cell, the world’s largest provider of regenerative cellular therapies, safety isn’t just a goal—it is our absolute baseline.
Under the leadership of CEO Dr. David Green, R3 Stem Cell has performed over 28,000 procedures globally without a single instance of disease transmission or deep infection. This impeccable 12-year safety record is the result of a “ridiculously serious” approach to donor screening and laboratory testing that defines our experts in regenerative medicine.
Unlike “street” blood donations or emergency tissue recovery, R3 Stem Cell utilizes tissues derived from scheduled C-sections. This controlled environment provides a massive safety advantage. Because the delivery is planned, our accredited donor agencies have the time to perform an exhaustive vetting process before the tissue is even collected.
The donor (the mother) undergoes a comprehensive medical and lifestyle questionnaire that covers every imaginable risk factor. This is a crucial part of understanding umbilical cord stem cell therapy:
Social & Lifestyle History: Extensive questions regarding smoking, vaping, and opioid use.
Recent Travel: Screening for exposure to regional outbreaks (e.g., West Nile or Zika).
Medical & Family History: Deep dives into family cancer history and autoimmune conditions.
Cosmetic Procedures: Screening for recent tattoos or piercings, which could carry a window of risk for blood-borne pathogens.
If a donor’s questionnaire is not 100% acceptable, the tissue is never even collected.
Once the tissue is recovered, it enters a multi-phase testing protocol. We screen for a full panel of communicable diseases using the most sensitive technology available. This ensures the advantages of mesenchymal stem cells are delivered without risk.
Required Infectious Disease Panels:
HIV & HTLV: Human Immunodeficiency Virus and Human T-Lymphotropic Virus.
Hepatitis: Multiple strains, including Hepatitis B Surface Antigens and Hepatitis C.
Syphilis: Comprehensive screening for treponemal antibodies.
West Nile Virus & CMV: Cytomegalovirus and regional viral threats.
Even after the initial donor screens and viral panels, the work is not done. At our labs—whether in the United States, Mexico, or internationally—the processed tissue undergoes an “All-or-Nothing” testing phase.
We send 10 to 30 vials from every single lot to an independent third-party lab. These vials are cultured for 14 days to check for:
The R3 Standard: If even one vial in a lot shows a positive result for a pathogen, the entire batch is destroyed. We make no mistakes when it comes to patient safety.
Every patient at R3 Stem Cell has the right to be fully informed. Every lot of stem cells we use comes with a Certificate of Analysis. This document is reviewed by the lab’s Medical Director and includes:
Safety Results:: Proof that all infectious disease tests were negative.
Viability Data: Confirmation that the cells are alive and active.
International Extras: In our Pakistan clinics and other global locations, we provide additional data points on the benefits of mesenchymal stem cell therapy.
Our commitment to safety is why patients feel comfortable choosing R3 for a wide range of debilitating conditions. By ensuring the highest purity, we avoid the inflammatory reactions often seen in lower-quality clinics.
Safe Treatment for Systemic Health:
Neurological Safety: Safe protocols for stroke recovery and brain injuries.
Orthopedic Sterility: Ensuring joint injections for arthritis or osteoarthritis are free from infection.
Spinal Integrity: Safely addressing spinal stenosis and failed back surgery syndrome.
No. Umbilical cord tissue cell therapy uses cells that are “immune-privileged.” They lack the surface markers (HLA) that trigger an immune rejection. In 24,000 cases, we have seen zero rejections.
Actually, bone marrow stem cell therapy often fails in older patients due to “aged” cells. Allogeneic umbilical cord tissue provides younger, more potent cells with a superior safety profile for chronic disease.
Yes. Our labs in Mexico and other countries follow the same strict safety protocols. You can learn more about is international stem cell therapy a good idea on our blog.
Safety is paramount, right up there with the successful outcomes our patients achieve. We take it “ridiculously seriously” so that you can focus on what matters: getting your life back. If you are ready to experience the most trusted name in regenerative medicine, visit us at R3StemCell.com.
Schedule your free consultation today:
Phone: +1 (844) GET-STEM
Global Presence: From Los Angeles to the UK, we offer elite care.
Learn More: Review our stem cell therapy FAQ for more safety information.
Contact Us
Consent alone is not sufficient. Donor mothers also undergo comprehensive medical screening, which typically includes: